272 related articles for article (PubMed ID: 31367958)
1. Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
Nilsson M; Jensen N; Gejl M; Bergmann ML; Storgaard H; Zander M; Miskowiak K; Rungby J
Diabetologia; 2019 Oct; 62(10):1948-1958. PubMed ID: 31367958
[TBL] [Abstract][Full Text] [Related]
2. Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial.
Gejl M; Gjedde A; Brock B; Møller A; van Duinkerken E; Haahr HL; Hansen CT; Chu PL; Stender-Petersen KL; Rungby J
Diabetologia; 2018 Mar; 61(3):551-561. PubMed ID: 29188338
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
[TBL] [Abstract][Full Text] [Related]
4. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
[TBL] [Abstract][Full Text] [Related]
5. Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study.
Koehler G; Heller S; Korsatko S; Roepstorff C; Rasmussen S; Haahr H; Pieber TR
Diabetologia; 2014 Jan; 57(1):40-9. PubMed ID: 24057153
[TBL] [Abstract][Full Text] [Related]
6. Characteristics influencing expected cognitive performance during hypoglycaemia in type 2 diabetes.
Petersen JZ; Nilsson M; Rungby J; Miskowiak KW
Psychoneuroendocrinology; 2019 Dec; 110():104431. PubMed ID: 31536941
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study.
Farrell CM; McNeilly AD; Fournier P; Jones T; Hapca SM; West D; McCrimmon RJ
Diabetologia; 2020 Apr; 63(4):853-863. PubMed ID: 31942669
[TBL] [Abstract][Full Text] [Related]
8. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counterregulatory hormones in subjects with functional hypoglycaemia.
Snorgaard O; Lassen LH; Rosenfalck AM; Binder C
J Intern Med; 1991 Apr; 229(4):343-50. PubMed ID: 2026987
[TBL] [Abstract][Full Text] [Related]
10. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
Hope SV; Knight BA; Shields BM; Hill AV; Choudhary P; Strain WD; McDonald TJ; Jones AG
Diabetologia; 2018 Jan; 61(1):66-74. PubMed ID: 28983693
[TBL] [Abstract][Full Text] [Related]
11. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes.
Cheyne EH; Sherwin RS; Lunt MJ; Cavan DA; Thomas PW; Kerr D
Diabet Med; 2004 Mar; 21(3):230-7. PubMed ID: 15008832
[TBL] [Abstract][Full Text] [Related]
12. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
13. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
[TBL] [Abstract][Full Text] [Related]
15. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
Verhulst CEM; Fabricius TW; Teerenstra S; Kristensen PL; Tack CJ; McCrimmon RJ; Heller S; Evans ML; Amiel SA; Pedersen-Bjergaard U; de Galan BE;
Diabetologia; 2022 Oct; 65(10):1601-1612. PubMed ID: 35867127
[TBL] [Abstract][Full Text] [Related]
16. Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
Drenthen LCA; de Baaij JHF; Rodwell L; van Herwaarden AE; Tack CJ; de Galan BE
Diabetologia; 2024 Jan; 67(1):52-61. PubMed ID: 37922013
[TBL] [Abstract][Full Text] [Related]
17. Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.
Steineck IIK; Ranjan A; Schmidt S; Clausen TR; Holst JJ; Nørgaard K
Diabetologia; 2019 Apr; 62(4):582-592. PubMed ID: 30643924
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial.
Ruissen MM; Torres-Peña JD; Uitbeijerse BS; Arenas de Larriva AP; Huisman SD; Namli T; Salzsieder E; Vogt L; Ploessnig M; van der Putte B; Merle A; Serra G; Rodríguez G; de Graaf AA; de Koning EJP; Delgado-Lista J; Sont JK;
Diabetologia; 2023 Dec; 66(12):2213-2225. PubMed ID: 37775611
[TBL] [Abstract][Full Text] [Related]
19. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
[TBL] [Abstract][Full Text] [Related]
20. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies.
Tagougui S; Taleb N; Legault L; Suppère C; Messier V; Boukabous I; Shohoudi A; Ladouceur M; Rabasa-Lhoret R
Diabetologia; 2020 Nov; 63(11):2282-2291. PubMed ID: 32740723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
